Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCINTOMICS Molecular, Applied Theranostics Technologies
Fürstenfeldbruck, Bavaria, Germanysci-att.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
SCI-att is the radiopharmaceutical tools and precursor subsidiary of Scintomics, supplying GMP and R&D precursors (e.g., PSMA I&T, SiFAlin-TATE, next‑generation PSMA inhibitors) and operating the GRP radiosynthesis platform used in routine clinical production of PET/SPECT tracers worldwide; its technologies underpin clinically developed radiohybrid PSMA and CXCR4 theranostic tracers that have reached late-stage clinical development and regulatory approval via licensees such as Blue Earth Diagnostics and others.[1][2][4][7][9][10]
- Therapeutic areas
- OncologyCardiovascularHematology
- Modalities
- RadiopharmaceuticalSmall molecule
- Industry
- Contract Manufacturing Organization
02
Partnerships
International Isotopes (distribution and service of GRP radiosynthesis platform in US and Canada)[5]Eckert & Ziegler Eurotope (CMO for GRP disposable cassettes)[7]
Beyond the preview
Go deeper on SCINTOMICS Molecular, Applied Theranostics Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SCINTOMICS Molecular, Applied Theranostics Technologies.